ロード中...
Trial watch: Dendritic cell-based anticancer immunotherapy
Dendritic cell (DC)-based vaccines against cancer have been extensively developed over the past two decades. Typically DC-based cancer immunotherapy entails loading patient-derived DCs with an appropriate source of tumor-associated antigens (TAAs) and efficient DC stimulation through a so-called “ma...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5543823/ https://ncbi.nlm.nih.gov/pubmed/28811970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1328341 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|